ArticleOncogenesis2013

Acquired PIK3CA amplification causes resistance to selective phosphoinositide 3-kinase inhibitors in breast cancer.

L-Y Huw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.